Alzheimer’s Association (ALZ): Tau Pipeline Enabling Program V (T-PEP) – Competitive LOI’s

T-PEP supports translational projects aimed at advancing potential therapies for tauopathies, including Alzheimer’s disease, progressive supranuclear palsy (PSP), and frontotemporal dementia (FTD). The program focuses on development candidate selection, lead optimization, in vivo proof-of-concept, and IND-enabling studies for tau or tau-related mechanisms. Projects centered on compound or target discovery are not responsive.
Funding: up to $750K for up to 2 years (Non-Profit)
https://www.alz.org/research/for_researchers/grants/types-of-grants/tau-pipeline-enabling-program-v#eligibility